uniQure (QURE) Reports Q4 Loss of EUR0.58/Share

Go back to uniQure (QURE) Reports Q4 Loss of EUR0.58/Share

Oppenheimer Cuts Price Target on uniQure (QURE) to $23 Following 4Q

April 5, 2016 8:13 AM EDT

Oppenheimer maintained an Outperform rating on uniQure BV (NASDAQ: QURE), and cut the price target to $23.00 (from $50.00),following the company's 4Q. QURE ended the year with 203.5M (~$230M USD) in cash which estimates show will fund operations through 2018. Next hemophilia data is set to come out in 2Q16, while... More